Tagged:

Hope for Millions As Nigeria Approves Malaria Vaccine

Nigeria has approved a new malaria vaccine developed by scientists at Oxford University, following Ghana's recent approval.

The head of Nigeria's National Agency for Food and Drugs Administration, Mojisola Adeyeye, said the vaccine, known as R21, would be used for the prevention of malaria in children aged between five months and three years - the most vulnerable group.

The approval is unique as it comes before the publication of final stage trial data, but it is believed to be 80% effective. Nigeria has the highest number of malaria deaths worldwide, with over 6,000 deaths annually, mostly affecting children in Sub-Saharan Africa.

InFocus

OMS / S. Hawkey

(file photo).

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.